Bank of New York Mellon Corp - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 28 filers reported holding LANTERN PHARMA INC in Q3 2023. The put-call ratio across all filers is 3.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$90,300
-39.5%
26,481
+0.0%
0.00%
Q2 2023$149,347
+16.8%
26,4800.0%0.00%
Q1 2023$127,898
-20.0%
26,4800.0%0.00%
Q4 2022$159,939
+25.9%
26,4800.0%0.00%
Q3 2022$127,000
-15.9%
26,4800.0%0.00%
Q2 2022$151,000
-20.9%
26,480
-1.1%
0.00%
Q1 2022$191,000
-10.3%
26,7650.0%0.00%
Q4 2021$213,000
-28.8%
26,7650.0%0.00%
Q3 2021$299,000
-23.5%
26,7650.0%0.00%
Q2 2021$391,000
+83.6%
26,765
+127.3%
0.00%
Q1 2021$213,00011,7750.00%
Other shareholders
LANTERN PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 75,000$255,7500.27%
Redmond Asset Management, LLC 46,506$158,5850.06%
Pathway Financial Advisors LLC 32,771$111,7490.04%
CARLSON CAPITAL L P 95,000$323,9500.02%
NewEdge Advisors, LLC 170,031$579,8280.01%
WOLFF WIESE MAGANA LLC 2,200$7,5020.01%
Meridian Wealth Management, LLC 16,660$56,8110.00%
Sigma Planning Corp 18,125$61,8060.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 30,000$102,3000.00%
WELLS FARGO & COMPANY/MN 4,492$15,3180.00%
View complete list of LANTERN PHARMA INC shareholders